A new way to lower cost and delays in new drug development

Globally, all pharmaceutical companies face the same challenge of finding effective drug targets that will translate into higher drug approval rates. Hyperdrive technology increases the accuracy of, and cuts the time required for, drug candidate selection, reducing the costs of drug development. The technology takes advantage of naturally occurring processes that allow genomic information from a cell to be translated into its corresponding protein library to be tested for new and emergent drug targets. Hyperdrive has been supported by the ON Accelerate program at CSIRO. http://www.oninnovation.com.au/en/ON-teams/ON-Tribe/ON-Accelerate4-Teams/Hyperdrive

Rate Idea

1 Star2 Stars3 Stars4 Stars5 Stars (7 votes, average: 5.00 out of 5)
Loading...

One response

What do you think?